Bringing Excellence to Science Education
The Conference specifically for Laboratory Technicians

Payment via credit card or invoice can be made online.

Alternatively, please print the ‘Registration form and tax invoice’ page from the LABCON2025 brochure. Fill out the form, then scan and email the completed form to Marg Scarlett at info@margscarlett.com

Unfortunately, due to high demand, accommodation for LABCON2025 is now fully booked.

Program Outline

Thursday 13 November
Keynote Speaker
Annual General Meeting
Concurrent Workshops
Exhibition
Conference Dinner

Friday 14 November
Keynote Speaker
Concurrent Workshops
Exhibition

Non Member

$675.00
$605.00
$625.00
$555.00
$160.00

LABCON2025 Keynote Speakers

Professor Kon Mouzakis is a Professor of Software and Technology Innovation at Deakin University. He is a Decision Support and Software Development expert with over 30 years of experience and currently holds the position of Co-Director of the Applied Artificial Intelligence Institute (A²I²). In 2018, Kon was appointed as the Director, Australian Research Council, Industrial Transformation Research Hub for Digital Enhanced Living, and in 2022, was conferred with the title of Deakin Distinguished Professor.

Over the past 5 years, Kon has attracted over $15 million in contract R&D and consulting activities. He has developed software solutions and concept demonstrators for organisations, including Dementia Australia, Black Dog Institute, Defence Science and Technology Group (DSTG), and the World Economic Forum. In collaboration with the Alfred Hospital’s Trauma Centre, he developed the Trauma Reception and Resuscitation Decision Support tool. This world first development reduced the number of errors that clinicians made in the first 30 minutes of patient arrival.

Kon is an advisor to the Trauma Centre of the Alfred Hospital, and to several technology companies in Australia. Kon is a tenured senior academic at Deakin University and, prior to this, at Swinburne University of Technology where he taught and researched in the areas of mobile technology, usability of complex systems and interface design.

Dr. Sylvie Callegari completed her PhD at the University of South Australia before moving to Göttingen, Germany for a postdoctor position in a lab studying mitochondria and its role in neurodegenerative disease.

In 2019, she returned to Australia to join Prof. David Komander’s lab at WEHI as a Senior Research Officer, where she has been leading the projects on mitochondrial quality control and Parkinson’s disease.

She uses a range of techniques in the lab, including cutting edge cell biology and structural biology techniques and has made key contributions to understanding what the Parkinson’s disease-linked protein PINK1 looks like (Callegari et al. Science 2025) and how it is activated (Gan, Callegari et al. Nature 2022; Gan, Callegari et al. Sci. Adv. 2024).

With this new understanding of how PINK1 works, Dr. Callegari is focussing on developing strategies to boost PINK1 activity to treat Parkinson’s disease.

ALL ENQUIRIES

Marg Scarlett
LABCON CONFERENCE MANAGER

info@margscarlett.com